Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

BioAge Labs (BIOA) Accumulated Depreciation & Amortization (2023 - 2026)

BioAge Labs' Accumulated Depreciation & Amortization history spans 3 years, with the latest figure at $482000.0 for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 29.92% to $482000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $482000.0, a 29.92% increase, with the full-year FY2025 number at $482000.0, up 29.92% from a year prior.
  • Accumulated Depreciation & Amortization hit $482000.0 in Q4 2025 for BioAge Labs, up from $413000.0 in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for BIOA hit a ceiling of $540000.0 in Q3 2024 and a floor of $371000.0 in Q4 2024.
  • Historically, Accumulated Depreciation & Amortization has averaged $442142.9 across 3 years, with a median of $419000.0 in 2023.
  • The widest YoY moves for Accumulated Depreciation & Amortization: up 29.92% in 2025, down 23.52% in 2025.
  • Tracing BIOA's Accumulated Depreciation & Amortization over 3 years: stood at $419000.0 in 2023, then decreased by 11.46% to $371000.0 in 2024, then grew by 29.92% to $482000.0 in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for BIOA at $482000.0 in Q4 2025, $413000.0 in Q3 2025, and $462000.0 in Q2 2025.